Heslop HE - Search Results

1

Leung WK, Ayanambakkam A, Heslop HE, Hill LC. Leung WK, et al. Among authors: heslop he. Curr Opin Immunol. 2022 Feb;74:46-52. doi: 10.1016/j.coi.2021.09.009. Epub 2021 Nov 17. Curr Opin Immunol. 2022. PMID: 34800921 Free PMC article. Review.

2

Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantation.

Aguilar LK, Rooney CM, Heslop HE. Aguilar LK, et al. Among authors: heslop he. Curr Opin Oncol. 1999 Mar;11(2):96-101. doi: 10.1097/00001622-199903000-00004. Curr Opin Oncol. 1999. PMID: 10188073 Review.

3

Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation.

Hale GA, Tong X, Benaim E, Cunningham JM, Heslop HE, Horwiz EM, Leung W, Rochester RJ, Shearer PD, Srivastava DK, Woodard JP, Bowman LC. Hale GA, et al. Among authors: heslop he. Bone Marrow Transplant. 2001 Jan;27(2):155-62. doi: 10.1038/sj.bmt.1702765. Bone Marrow Transplant. 2001. PMID: 11281384

4

Genetically engineered T-cells for adoptive immunotherapy.

Pule M, Bollard CM, Heslop HE. Pule M, et al. Among authors: heslop he. Curr Opin Mol Ther. 2002 Oct;4(5):467-75. Curr Opin Mol Ther. 2002. PMID: 12435048 Review.

5

Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma.

Straathof KC, Leen AM, Buza EL, Taylor G, Huls MH, Heslop HE, Rooney CM, Bollard CM. Straathof KC, et al. Among authors: heslop he. J Immunol. 2005 Sep 15;175(6):4137-47. doi: 10.4049/jimmunol.175.6.4137. J Immunol. 2005. PMID: 16148164

6

Adoptive T-cell transfer in cancer immunotherapy.

Tey SK, Bollard CM, Heslop HE. Tey SK, et al. Among authors: heslop he. Immunol Cell Biol. 2006 Jun;84(3):281-9. doi: 10.1111/j.1440-1711.2006.01441.x. Immunol Cell Biol. 2006. PMID: 16681825 Review.

7

Viral lymphomagenesis.

Ahmed N, Heslop HE. Ahmed N, et al. Among authors: heslop he. Curr Opin Hematol. 2006 Jul;13(4):254-9. doi: 10.1097/01.moh.0000231423.38525.fe. Curr Opin Hematol. 2006. PMID: 16755222 Review.

8

T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells.

Vera J, Savoldo B, Vigouroux S, Biagi E, Pule M, Rossig C, Wu J, Heslop HE, Rooney CM, Brenner MK, Dotti G. Vera J, et al. Among authors: heslop he. Blood. 2006 Dec 1;108(12):3890-7. doi: 10.1182/blood-2006-04-017061. Epub 2006 Aug 22. Blood. 2006. PMID: 16926291 Free PMC article.

9

Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.

Savoldo B, Rooney CM, Di Stasi A, Abken H, Hombach A, Foster AE, Zhang L, Heslop HE, Brenner MK, Dotti G. Savoldo B, et al. Among authors: heslop he. Blood. 2007 Oct 1;110(7):2620-30. doi: 10.1182/blood-2006-11-059139. Epub 2007 May 16. Blood. 2007. PMID: 17507664 Free PMC article.

10

Regression of experimental medulloblastoma following transfer of HER2-specific T cells.

Ahmed N, Ratnayake M, Savoldo B, Perlaky L, Dotti G, Wels WS, Bhattacharjee MB, Gilbertson RJ, Shine HD, Weiss HL, Rooney CM, Heslop HE, Gottschalk S. Ahmed N, et al. Among authors: heslop he. Cancer Res. 2007 Jun 15;67(12):5957-64. doi: 10.1158/0008-5472.CAN-06-4309. Cancer Res. 2007. PMID: 17575166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters